digital central bank currency, Top

On the 13th, the No.20 rubber fell by 2.05%, and the latest main contract positions changed as follows. According to the exchange data, as of December 13th, the main contract No.20 rubber 2502 was closed, with a turnover of 159,100 lots. The position data showed that the top 20 seats were clear, and the difference position was 5,142 lots. A total of 205,200 lots were traded in the No.20 rubber futures contract, an increase of 8,176 lots over the previous day. The first 20 seats in the contract held 84,200 lots, an increase of 812 lots over the previous day. Short positions in the top 20 seats of the contract were 94,500 lots, a decrease of 1,708 lots from the previous day. (Sina Futures)Weixing Co., Ltd.: Compared with the first half of the year, the growth rate of acquiring orders in the second half of the year gradually declined, but the overall growth rate still maintained. Weixing Co., Ltd. recently said in a conference call that due to the influence of the terminal consumption boom, downstream brand customers were cautious in placing orders, and the growth rate of acquiring orders in the second half of the year gradually declined compared with the first half of the year, but the overall growth rate still maintained. In recent years, the company has mainly focused on promoting globalization strategy, intelligent manufacturing strategy and improving manufacturing level, technical level and product quality, and achieved certain results. 

Today, Shengguang Group bought 170 million yuan and sold 171 million yuan at the daily limit, with a turnover of 6.558 billion yuan and a turnover rate of 3.239%. After-hours data show that the special seats of Shenzhen Stock Connect bought 170 million yuan and sold 171 million yuan.Asia-Pacific Pharmaceuticals: The new specifications of cefmetazole sodium for injection were approved, and Asia-Pacific Pharmaceuticals announced that the company was approved by National Medical Products Administration, and the new specifications of cefmetazole sodium for injection were 0.5g and 2g, which further enriched the product categories on the basis of the original 1g specifications. The annual sales income of this drug in 2023 was 96.3946 million yuan, accounting for 22.92% of the company's operating income. New specifications are helpful to market promotion and competitiveness improvement, but drug production and sales are affected by policies and market environment, and there are uncertainties.The 30-year main contract of treasury bond futures rose to 0.62%, which continued to hit a new high. In addition, the 10-year main contract rose by 0.37%, the 5-year main contract rose by 0.27%, and the 2-year main contract rose by 0.09%, which was another record.

The 30-year main contract of treasury bond futures rose to 0.62%, which continued to hit a new high. In addition, the 10-year main contract rose by 0.37%, the 5-year main contract rose by 0.27%, and the 2-year main contract rose by 0.09%, which was another record.The 30-year main contract of treasury bond futures rose to 0.62%, which continued to hit a new high. In addition, the 10-year main contract rose by 0.37%, the 5-year main contract rose by 0.27%, and the 2-year main contract rose by 0.09%, which was another record.On the 13th, the 30-year treasury bond futures rose by 0.60%, and the latest main contract positions changed as follows. According to the data of the exchange, as of December 13th, the main contract 30-year treasury bond futures closed at 2503, up or down by +0.60%, with a turnover of 71,900 lots. The position data showed that the top 20 seats were clear, and the difference position was 3,777 lots. The total number of 30-year treasury bond futures contracts was 82,700 lots, an increase of 4,416 lots over the previous day. The first 20 seats in the contract held 78,000 lots, a decrease of 1,313 lots from the previous day. The top 20 seats in the contract held 85,000 short positions, a decrease of 1,049 lots from the previous day. (Sina Futures)